Encellin: Funding, Investors & Team (Oct 2026)
A new device for enclosing cell-based therapeutics is being created by Encellin. The company consists of specialized professionals who are committed to exploring and enhancing advanced therapies. Their primary goal is to assist individuals suffering from chronic illnesses, beginning with Type 1 diabetes. Encellin was established in 2016 and is headquartered in San Francisco, California.
Encellin has raised $9.9M across 1 funding round on record, the most recent a Series A of $9.9M announced in Dec 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Encellin Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Encellin Funding Rounds
Encellin Founders and Leadership Team
No contact details are on record for this team yet.
Encellin Funding Compared to Other Biotechnology Startups
Encellin's latest round of $9.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Encellin in Biotechnology and San Francisco
Companies Similar to Encellin
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Encellin Funding FAQs
What does Encellin do?
A new device for enclosing cell-based therapeutics is being created by Encellin. The company consists of specialized professionals who are committed to exploring and enhancing advanced therapies. Their primary goal is to assist individuals suffering from chronic illnesses, beginning with Type 1 diabetes. Encellin was established in 2016 and is headquartered in San Francisco, California.
How much funding has Encellin raised?
Encellin has raised $9.9M across 1 round on record. The most recent is a Series A of $9.9M announced in Dec 2023.
When did Encellin last raise funding?
Encellin's most recent funding round on record is a Series A of $9.9M, announced in Dec 2023.
Who founded Encellin?
FundedIQ lists Grace Wei (Founder) at Encellin.
Where is Encellin headquartered?
Encellin is based in San Francisco, California, United States.
How many employees does Encellin have?
Encellin is in the 1-10 employee band.
How does Encellin's funding compare to other Biotechnology startups?
Encellin's latest round of $9.9M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Encellin Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Encellin is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.